Clinical trial
Randomized, Double-blind, Placebo-controlled, Dose-escalation, Repeated and Single Oral Dosing Phase I Study to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Temanogrel Co-administered With Aspirin and Clopidogrel
NCT02419820 is registered in ClinicalTrials.gov with IlDong Pharmaceutical Co Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Double-blind, Placebo-controlled, Dose-escalation, Repeated and Single Oral Dosing Phase I Study to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Temanogrel Co-administered With Aspirin and Clopidogrel
- Lead sponsor
- IlDong Pharmaceutical Co Ltd
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- March 31, 2015
- Completion date
- April 30, 2016
- Enrollment
- 104 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.